MLKL and COVID-19: TF, COPB2, IL‐18R1 in peripheral blood EVs, activated caspase‐3, and MLKL in platelet EVs exhibit strong correlations with the risk of microthrombosis, malignant disease progression, and hospital stay in patients with COVID‐19.